Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cultured Circulating Tumor Cells - Development of a Novel Platform for Drug Discovery and in Vitro Chemosensitivity Testing in Prostate and Other Cancers

NCT02123862 is registered in ClinicalTrials.gov with Oscar Goodman, Jr. as lead sponsor.

NCT NCT02123862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02123862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cultured Circulating Tumor Cells - Development of a Novel Platform for Drug Discovery and in Vitro Chemosensitivity Testing in Prostate and Other Cancers
Lead sponsor
Oscar Goodman, Jr.
Phase
Observational
Overall status
Unknown status
Start date
April 30, 2014
Completion date
April 30, 2018
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer